Drug Profile
HA 192
Latest Information Update: 02 Sep 2002
Price :
$50
*
At a glance
- Originator Hindustan Antibiotics
- Class Antifungals
- Mechanism of Action Cell membrane permeability enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Mycoses
Most Recent Events
- 27 Sep 1999 New profile
- 27 Sep 1999 Preclinical development for Mycoses in India (Unknown route)